Moreover, serum SP-D and KL-6 levels are generally elevated in fibrosing ILD; however, the positivity rate and degree of elevation vary depending on ILD subtypes [23–26], and screening using these two biomarkers might not have identified all lung fibrosis cases. This evidence concerns the gene SFTPD and interstitial lung disease.